Role of Systemic Inflammation Scores for Prediction of Clinical Outcomes in Patients Treated with Atazanavir Not Boosted by Ritonavir in the Italian MASTER Cohort.

Maria Concetta Postorino,Mattia Prosperi,Emanuele Focà,Eugenia Quiros-Roldan,Elisa Di Filippo,Franco Maggiolo,Alberto Borghetti,Nicoletta Ladisa,Massimo Di Pietro,Andrea Gori,Laura Sighinolfi,Angelo Pan,Nicola Mazzini,Carlo Torti

BMC infectious diseases（2017）

引用 0|浏览31

暂无评分

摘要

Atazanavir (ATV) not boosted by ritonavir (uATV) has been frequently used in the past for switching combination antiretroviral therapy (cART). However, the clinical outcomes and predictors of such strategy are unknown.

查看译文

关键词

HIV,Atazanavir,Ritonavir,Clinical events,Systemic inflammation scores

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要